APP Receives Two FDA Approvals For Fludarabine Phosphate (Medical News Today)
Abraxis Pharmaceutical Products (APP), the hospital-based business of Abraxis BioScience, Inc. (NASDAQ:ABBI), announced two approvals from U.S. Food and Drug Administration (FDA) to market the liquid and lyophilized versions of Fludarabine phosphate. [click link for full article]

FDA Approves Chemotherapy Drug Ixempra For Advanced Breast Cancer (Medical News Today)
The US Food and Drug Administration (FDA) has approved a new chemotherapy drug called Ixempra (ixabepilone) for the treatment of advanced breast cancer.The announcement was made to the press by Bristol-Myers Squibb on 17th October, the maker of the new drug, who also said the drug will be available "within days". [click link for full article]

APP Receives Two FDA Approvals for Fludarabine Phosphate (Business Wire via Yahoo! Finance)
SCHAUMBURG, Ill.----Abraxis Pharmaceutical Products , the hospital-based business of Abraxis BioScience, Inc. , today announced two approvals from U.S. Food and Drug Administration to market the liquid and lyophilized versions of Fludarabine phosphate.